ArticleHaematologica2018

A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.

Paolo Strati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.